Home

Sage Bionetworks announces the launch of the Agora platform, an interactive, web-based tool that allows researchers to share and explore curated genomic analyses of Alzheimer’s Disease (AD). Agora hosts a list of over a hundred nascent drug targets for AD that were nominated by AD researchers as part of the National Institute on Aging’s Accelerating Medicines Partnership- Alzheimer’s Disease (AMP-AD) research program.

Sage Bionetworks announces the Digital Health Catalyst Program, which will be accepting applications for innovative uses of digital health tools in biomedical research. The Digital Health Catalyst Program is a competition available to researchers conducting promising research studies. Winning applicants will receive support from Sage Bionetworks to accelerate the inclusion of digital health technologies into their research programs. First round of applications are due July 31!

UCSF and Sage Bionetworks announce My BP Lab, a research app designed to help study participants track their blood pressure and stress levels using new sensors included on the Samsung Galaxy S9 and S9+ smartphones. The study, developed collaboratively by UCSF and Sage Bionetworks, marks the groundbreaking use of a smartphone sensor capable of measuring body signals for blood pressure estimation, and is open for enrollment to the general public.

Sage Bionetworks, in a broad partnership led by OHSU, has been awarded the new CTSA Program National Center for Data to Health (CD2H). This award will coalesce and coordinate informatics activities across the Clinical and Translational Science Award (CTSA) Program, a network of more than 50 medical research institutions, to provide collaborative clinical and translational research infrastructure.